Respiri (KMLXF) Stock Price, News & Analysis

Company Overview

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.06 to $0.06
• 52-Week Range: $0.04 to $0.05
• Volume: N/A
• Average Volume: 6,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KMLXF Stock Analysis - Frequently Asked Questions

How have KMLXF shares performed this year?

Respiri's stock was trading at $0.0581 at the beginning of 2025. Since then, KMLXF stock has increased by 0.0% and is now trading at $0.0581.

How do I buy shares of Respiri?

Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/17/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:KMLXF
• CIK: N/A
• Web: www.respiri.co
• Phone: 61 3 9653 9160
• Fax: 61 -0-3 9602 3606
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.07 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.07